Kaori Yoshida was stripped of her fourth-place finish in December’s Honolulu Marathon on Thursday, when the Japan Anti-Doping Agency revealed she had tested positive for a banned substance.
Yoshida, 32, received a one-year suspension from the agency after testing positive for the performance-enhancing drug erythropoietin (EPO) at the Honolulu race. The ban is retroactive from Jan. 18.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.